JP2022513363A5 - - Google Patents
Info
- Publication number
- JP2022513363A5 JP2022513363A5 JP2021546056A JP2021546056A JP2022513363A5 JP 2022513363 A5 JP2022513363 A5 JP 2022513363A5 JP 2021546056 A JP2021546056 A JP 2021546056A JP 2021546056 A JP2021546056 A JP 2021546056A JP 2022513363 A5 JP2022513363 A5 JP 2022513363A5
- Authority
- JP
- Japan
- Prior art keywords
- glp1
- fusion protein
- pharmaceutical composition
- gdf15 fusion
- gdf15
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024135217A JP2024170428A (ja) | 2018-10-22 | 2024-08-14 | グルカゴン様ペプチド1(glp1)-増殖分化因子15(gdf15)融合タンパク質及びその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862748603P | 2018-10-22 | 2018-10-22 | |
| US62/748,603 | 2018-10-22 | ||
| PCT/IB2019/059029 WO2020084496A1 (en) | 2018-10-22 | 2019-10-22 | Glucagon like peptide 1 (glp1)-growth differentiation factor 15 (gdf15) fusion proteins and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024135217A Division JP2024170428A (ja) | 2018-10-22 | 2024-08-14 | グルカゴン様ペプチド1(glp1)-増殖分化因子15(gdf15)融合タンパク質及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022513363A JP2022513363A (ja) | 2022-02-07 |
| JP2022513363A5 true JP2022513363A5 (cg-RX-API-DMAC10.html) | 2022-10-27 |
| JP7539902B2 JP7539902B2 (ja) | 2024-08-26 |
Family
ID=70330680
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021546056A Active JP7539902B2 (ja) | 2018-10-22 | 2019-10-22 | グルカゴン様ペプチド1(glp1)-増殖分化因子15(gdf15)融合タンパク質及びその使用 |
| JP2024135217A Pending JP2024170428A (ja) | 2018-10-22 | 2024-08-14 | グルカゴン様ペプチド1(glp1)-増殖分化因子15(gdf15)融合タンパク質及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024135217A Pending JP2024170428A (ja) | 2018-10-22 | 2024-08-14 | グルカゴン様ペプチド1(glp1)-増殖分化因子15(gdf15)融合タンパク質及びその使用 |
Country Status (24)
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10336812B2 (en) * | 2016-05-10 | 2019-07-02 | Janssen Biotech, Inc. | GDF15 fusion proteins and uses thereof |
| MY205905A (en) | 2018-10-22 | 2024-11-20 | Janssen Pharmaceutica Nv | Glucagon like peptide 1 (glp1)-growth differentiation factor 15 (gdf15) fusion proteins and uses thereof |
| CN113474363A (zh) * | 2018-11-20 | 2021-10-01 | 詹森药业有限公司 | 用于降低体重和/或减少食物摄取量的gdf15类似物和方法 |
| JP7536030B2 (ja) * | 2019-03-08 | 2024-08-19 | アムジエン・インコーポレーテツド | 増殖分化因子15併用療法 |
| WO2021136223A1 (en) | 2019-12-31 | 2021-07-08 | Beijing Ql Biopharmaceutical Co., Ltd. | Fusion proteins of glp-1 and gdf15 and conjugates thereof |
| US11981718B2 (en) * | 2020-05-27 | 2024-05-14 | Ampsource Biopharma Shanghai Inc. | Dual-function protein for lipid and blood glucose regulation |
| WO2022221291A2 (en) * | 2021-04-12 | 2022-10-20 | University Of Florida Research Foundation Incorporated | Compositions and methods for treating obesity |
| EP4351627A4 (en) * | 2021-05-21 | 2025-06-04 | Yuhan Corporation | COMPOSITION FOR COMBINATION THERAPY COMPRISING A GROWTH DIFFERENTIATION FACTOR 15 VARIANT AND A GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONIST |
| AU2022278933A1 (en) * | 2021-05-21 | 2023-12-07 | Yuhan Corporation | Composition for preventing or treating non-alcoholic fatty liver disease or non-alcoholic steatohepatitis comprising growth differentiation factor-15 variant |
| WO2023154953A1 (en) | 2022-02-14 | 2023-08-17 | Ngm Biopharmaceuticals, Inc. | Gdf15 polypeptides for treating and preventing autoimmune diseases |
| EP4619423A1 (en) * | 2022-11-18 | 2025-09-24 | Yuhan Corporation | Dual function proteins and uses thereof |
| CN116813742A (zh) * | 2022-11-22 | 2023-09-29 | 杭州博茵生物技术有限公司 | 人gdf-15抗原表位肽、抗原、抗体、试剂盒及应用 |
| WO2024144431A1 (ru) * | 2022-12-29 | 2024-07-04 | Авва Фармасьютикалс Лтд | Новый штамм-продуцент escherichia coli, продуцирующий гибридный белок cbd-hs-es-glp1, и способ получения полипептида glp-1 |
| JP2026505740A (ja) * | 2023-01-20 | 2026-02-18 | コリア アドバンスト インスティチュート オブ サイエンス アンド テクノロジー | Gfralを標的にするアンチセンスオリゴマー及びこの用途 |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU8591198A (en) | 1997-07-31 | 1999-02-22 | Johns Hopkins University School Of Medicine, The | Growth differentiation factor-15 |
| SI1724284T1 (sl) * | 2000-12-07 | 2009-12-31 | Lilly Co Eli | Glp-1 fuzijski proteini |
| US7919084B2 (en) | 2002-06-17 | 2011-04-05 | St. Vincent's Hospital Sydney Limited | Methods of diagnosis, prognosis and treatment of cardiovascular disease |
| ES2371072T3 (es) | 2003-06-12 | 2011-12-27 | Eli Lilly And Company | Proteínas de fusión análogas de glp-1. |
| US20090099031A1 (en) | 2005-09-27 | 2009-04-16 | Stemmer Willem P | Genetic package and uses thereof |
| KR20090039787A (ko) | 2006-07-18 | 2009-04-22 | 센토코 인코포레이티드 | 인간 glp-1 모방체, 조성물, 방법 및 용도 |
| AR071874A1 (es) | 2008-05-22 | 2010-07-21 | Bristol Myers Squibb Co | Proteinas de dominio de armazon basadas en fibronectina multivalentes |
| CA2740632A1 (en) | 2008-10-31 | 2010-05-06 | St. Vincent's Hospital Sydney Limited | Methods of prognosis in chronic kidney disease |
| MX2011007889A (es) | 2009-02-06 | 2011-08-15 | Syngenta Participations Ag | Modificacion de enzima multidominio para la expresion en plantas. |
| TW201101990A (en) | 2009-07-08 | 2011-01-16 | zhen-zheng Huang | Plant media |
| EP2456454A4 (en) | 2009-07-20 | 2013-03-20 | Univ Nat Cheng Kung | FOR AV-3-INTEGRIN SELECTIVE POLYPEPTIDE AND PHARMACEUTICAL USES THEREOF ASSOCIATED WITH A HUMAN SERUM ALUMINUM (HSA) VARIATION |
| WO2012091564A2 (en) | 2010-12-27 | 2012-07-05 | Apo-T B.V. | A cross-linking polypeptide that induces apoptosis |
| US8883735B2 (en) | 2011-11-04 | 2014-11-11 | Novartis Ag | Low density lipoprotein-related protein 6 (LRP6)-half life extender constructs |
| KR20140125803A (ko) | 2012-01-26 | 2014-10-29 | 암젠 인크 | 성장 분화 인자 15(gdf-15) 폴리펩타이드들 |
| JP6254146B2 (ja) | 2012-03-27 | 2017-12-27 | エヌジーエム バイオファーマシューティカルス,インコーポレーテッド | 代謝障害を治療するための組成物および方法 |
| KR102373193B1 (ko) * | 2012-11-21 | 2022-03-10 | 얀센 바이오테크 인코포레이티드 | 이중특이성 EGFR/c-Met 항체 |
| US9695228B2 (en) | 2012-11-21 | 2017-07-04 | Janssen Biotech, Inc. | EGFR and c-Met fibronectin type III domain binding molecules |
| ES3066738T3 (en) | 2012-12-21 | 2026-05-14 | Aveo Pharmaceuticals Inc | Anti-gdf15 antibodies |
| NZ709913A (en) | 2013-01-25 | 2019-05-31 | Janssen Biotech Inc | Kv1.3 antagonists and methods of use |
| US9161966B2 (en) | 2013-01-30 | 2015-10-20 | Ngm Biopharmaceuticals, Inc. | GDF15 mutein polypeptides |
| CA2899170C (en) | 2013-01-30 | 2022-08-02 | Ngm Biopharmaceuticals, Inc. | Compositions and methods of use in treating metabolic disorders |
| AU2014283221A1 (en) * | 2013-06-20 | 2015-12-03 | Novo Nordisk A/S | GLP-1 derivatives and uses thereof |
| LT3027642T (lt) * | 2013-07-31 | 2020-10-12 | Amgen Inc. | Augimo ir diferenciacijos faktoriaus 15(gdf-15) konstruktai |
| GB201403794D0 (en) * | 2014-03-04 | 2014-04-16 | Univ Manchester | Novel antimicrobial peptides |
| EP3157947A1 (en) | 2014-06-23 | 2017-04-26 | Novartis AG | Hsa-gdf-15 fusion polypeptide and use thereof |
| US10588980B2 (en) * | 2014-06-23 | 2020-03-17 | Novartis Ag | Fatty acids and their use in conjugation to biomolecules |
| WO2015197446A1 (en) | 2014-06-24 | 2015-12-30 | Novo Nordisk A/S | Mic-1 fusion proteins and uses thereof |
| JP6704358B2 (ja) | 2014-07-30 | 2020-06-03 | エヌジーエム バイオファーマシューティカルズ インコーポレイテッド | 代謝障害を治療するための組成物および使用方法 |
| AU2015339134B2 (en) | 2014-10-30 | 2021-06-17 | Acceleron Pharma Inc. | Methods and compositions using GDF15 polypeptides for increasing red blood cells |
| CN106687128B (zh) | 2014-10-31 | 2022-05-10 | Ngm生物制药有限公司 | 用于治疗代谢病症的组合物和方法 |
| GB201512733D0 (en) | 2015-07-20 | 2015-08-26 | Genagon Therapeutics Ab | Therapeutic agents for treating conditions associated with elevated GDF15 |
| US20190000923A1 (en) | 2015-12-22 | 2019-01-03 | Novartis Ag | Methods of treating or ameliorating metabolic disorders using growth differentiation factor 15 (gdf-15) |
| JP2019510739A (ja) | 2016-02-29 | 2019-04-18 | イーライ リリー アンド カンパニー | Gfral受容体療法 |
| US10336812B2 (en) | 2016-05-10 | 2019-07-02 | Janssen Biotech, Inc. | GDF15 fusion proteins and uses thereof |
| KR102433503B1 (ko) | 2016-05-24 | 2022-08-18 | 노보 노르디스크 에이/에스 | Mic-1 화합물 및 이것의 사용 |
| WO2018071493A1 (en) | 2016-10-12 | 2018-04-19 | Janssen Biotech, Inc. | Methods for screening for modulators of gdf15-like biological activity |
| TWI710377B (zh) | 2017-05-23 | 2020-11-21 | 丹麥商諾佛 儂迪克股份有限公司 | Mic-1化合物及其用途 |
| MY205905A (en) | 2018-10-22 | 2024-11-20 | Janssen Pharmaceutica Nv | Glucagon like peptide 1 (glp1)-growth differentiation factor 15 (gdf15) fusion proteins and uses thereof |
| CN113474363A (zh) | 2018-11-20 | 2021-10-01 | 詹森药业有限公司 | 用于降低体重和/或减少食物摄取量的gdf15类似物和方法 |
-
2019
- 2019-10-22 MY MYPI2021002147A patent/MY205905A/en unknown
- 2019-10-22 ES ES19875615T patent/ES3011982T3/es active Active
- 2019-10-22 CR CR20210193A patent/CR20210193A/es unknown
- 2019-10-22 BR BR112021007376-0A patent/BR112021007376A2/pt unknown
- 2019-10-22 JP JP2021546056A patent/JP7539902B2/ja active Active
- 2019-10-22 CN CN202411964603.3A patent/CN119751697A/zh active Pending
- 2019-10-22 AU AU2019368816A patent/AU2019368816B2/en active Active
- 2019-10-22 US US17/309,114 patent/US11713345B2/en active Active
- 2019-10-22 MX MX2021004665A patent/MX428581B/es unknown
- 2019-10-22 EP EP25150545.9A patent/EP4520343A3/en active Pending
- 2019-10-22 CA CA3116983A patent/CA3116983A1/en active Pending
- 2019-10-22 PE PE2021000543A patent/PE20211078A1/es unknown
- 2019-10-22 KR KR1020217015121A patent/KR20210081389A/ko not_active Ceased
- 2019-10-22 EP EP19875615.7A patent/EP3870211B1/en active Active
- 2019-10-22 SG SG11202103990QA patent/SG11202103990QA/en unknown
- 2019-10-22 CN CN201980085401.2A patent/CN113226351B/zh active Active
- 2019-10-22 WO PCT/IB2019/059029 patent/WO2020084496A1/en not_active Ceased
- 2019-10-22 EA EA202191105A patent/EA202191105A1/ru unknown
-
2021
- 2021-04-13 IL IL282297A patent/IL282297B2/en unknown
- 2021-04-19 CL CL2021000987A patent/CL2021000987A1/es unknown
- 2021-04-20 CO CONC2021/0005051A patent/CO2021005051A2/es unknown
- 2021-04-21 DO DO2021000075A patent/DOP2021000075A/es unknown
- 2021-04-21 PH PH12021550885A patent/PH12021550885A1/en unknown
- 2021-04-22 JO JOP/2021/0084A patent/JOP20210084A1/ar unknown
- 2021-04-22 SA SA521421825A patent/SA521421825B1/ar unknown
- 2021-04-22 EC ECSENADI202128914A patent/ECSP21028914A/es unknown
-
2023
- 2023-06-09 US US18/332,690 patent/US12275770B2/en active Active
-
2024
- 2024-08-14 JP JP2024135217A patent/JP2024170428A/ja active Pending
-
2025
- 2025-03-06 US US19/072,966 patent/US20250197468A1/en active Pending
- 2025-04-30 AU AU2025203071A patent/AU2025203071A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11858975B2 (en) | Multi-domain active protein for treating metabolic diseases | |
| US8889619B2 (en) | Fusion protein of Exendin-4 and its analog, preparation method and use thereof | |
| JP7268202B2 (ja) | 代謝性疾患を治療するための融合タンパク質 | |
| US8304386B2 (en) | Long-acting growth hormone and methods of producing same | |
| US10538586B2 (en) | Compositions and methods for treating fatty tissue buildup | |
| JP7282899B2 (ja) | 線維芽細胞成長因子21変異体、その融合タンパク質とその使用 | |
| CN114621339B (zh) | 一种长效glp-1衍生物 | |
| AU2020233876B2 (en) | Growth differentiation factor 15 combination therapy | |
| CN104010650A (zh) | 长效生长激素及其生产方法 | |
| JP7058670B2 (ja) | 増殖分化因子15融合タンパク質 | |
| WO2011020319A1 (zh) | 调节血糖血脂的融合蛋白及其制备方法和应用 | |
| TW201414750A (zh) | 用於治療代謝症狀的融合蛋白 | |
| JP2010031018A5 (cg-RX-API-DMAC10.html) | ||
| US12551541B2 (en) | Albumin bound macromolecule tri-agonist activating GLP 1/GIP/glucagon receptors and methods therefor | |
| US10736970B2 (en) | Polypeptide complex of titin-telethonin beta-pleated sheet structure as polypeptide drug carrier, method of using the polypeptide complex, and fusion protein complex thereof | |
| WO2006002532A1 (en) | Methods and compositions using cd3 agonists | |
| WO2026082147A1 (zh) | 一种双靶点受体激动剂融合蛋白及其应用 | |
| CN105254763B (zh) | 一种重组促胰岛素分泌素融合蛋白、制备方法及其应用 | |
| CN114891090B (zh) | 一种酰化的长效glp-1衍生物 | |
| MX2012005912A (es) | Conjugado de polipeptido. | |
| US11400135B2 (en) | Compositions and methods for treating obesity and hyperphagia | |
| WO2022143516A1 (zh) | 一种人glp-1多肽变体及其应用 | |
| WO2021083306A1 (zh) | Glp-1/gcg双受体激动剂多肽 | |
| JP6033433B2 (ja) | アポリポタンパク質aivを用いて高血糖障害を治療する方法 | |
| JP2008546816A (ja) | エキセンディン4ポリペプチドフラグメントおよびその使用 |